Archive

Author: Salim Rezaie

Rebellion in EM 2019: Why Tramadol Should Be Called Tramadon’t…The Dirty Truth

Background: Tramadol is a centrally acting synthetic opioid analgesic approved for use in the United States in 1995 by the Food and Drug Administration. In 2014, the Drug Enforcement Agency classified tramadol as a Schedule IV controlled substance. ~41 million …

Read More
Toxicology

Rebellion in EM 2019: Pro/Con Debate – Epinephrine in Out of Hospital Cardiac Arrest (OHCA)

Background: Epinephrine (adrenaline) has been used in advanced life support in cardiac arrest since the early 1960s. Despite the routine recommendation for its use, evidence to support administration is less than ideal.  Although it is clear from multiple observational studies …

Read More
Resuscitation

REBEL Cast Ep71: 2nd Line Therapy for Pediatric Status Epilepticus – EcLiPSE & ConSEPT

Background: Convulsive status epilepticus is the most common pediatric neurological emergency worldwide.  Currently, phenytoin (UK & Europe) or fosphenytoin (USA) is the recommended second-line IV anticonvulsant for the treatment of pediatric status epilepticus.  Some evidence and providers however suggest that …

Read More
Pediatrics

Rebellion in EM 2019: What the Fluid? Wieters vs Bryant

Normal saline started being used based on work done in the 1830s with cholera.  We are still doing the same thing the same way and it’s not until recently we have begun to ask the hard questions about why we …

Read More
Endocrine, Metabolic, Fluid, and Electrolytes

Does CRP Help Reduce Antibiotic Prescriptions in Acute COPD Exacerbations?

Background: Unwarranted use of antibiotics has several deleterious effects which include, antimicrobial resistance, wasted resources, adverse effects, negative affect on the microbiome of patients, and distracts from potentially more effective interventions. There has recently been a huge push for tests such …

Read More
Infectious DiseaseThoracic and Respiratory

Sponsored